Prevalence of Diabetes Mellitus in Patients Attending Zambuk General Hospital

Maori, Lynn; Ezekiel, Dorcas; Bilal, Joy; Alibe, Wasa; Haruna, Ishaku L.

doi:10.9790/3008-09250811

Cited by 8 publications

(10 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this study, we found that TB-HIV co-infection was 18.2%. This finding was in line with studies conducted in India (17%), Nigeria (16.8%, 14.4%, 9.6% [1][2][3][4]. However, relatively higher prevalence has been reported from Nepal (27.3%) and Nigeria (22.7%) [5,6], and lower results were reported from Northern Tanzania (8.3%) [7].…”

Section: Discussionsupporting

confidence: 88%

Prevalence and determinants of Tuberculosis among HIV infected patients in south Ethiopia

Fekadu

Teshome

Alemu

2015

J Infect Dev Ctries

View full text Add to dashboard Cite

Introduction: Tuberculosis (TB) is a chronic infectious disease that has represented a major health problem over the centuries. The human immune deficiency virus (HIV)/AIDS has substantially altered the epidemiology of TB by increasing the risk of reactivating latent TB, increasing chance of TB infection once exposed to tubercle bacilli (re-infection) and by increasing the risk of rapid progression soon after infection. Methodology: This study employs a retrospective review analysis of patient medical records. A total of 499 HIV/AIDS patient cards were reviewed and variables were recorded. Frequencies and odds ratio were calculated to determine prevalence and associated risk factors respectively. Results: A total of 499 HIV/AIDS positive patient cards were reviewed. Ninety one (18.2%) of the study participants were found to have tuberculosis of which 20 (22%), 58 (64%) and 13 (14%) were smear positive, smear negative and extra-pulmonary tuberculosis cases, respectively. In multivariate logistic regression being female (AOR=0.

show abstract

Section: Discussionsupporting

confidence: 88%

Prevalence and determinants of Tuberculosis among HIV infected patients in south Ethiopia

Fekadu

Teshome

Alemu

2015

J Infect Dev Ctries

View full text Add to dashboard Cite

show abstract

“…1 Worldwide prevalence of DM was 285 million people in 2010 while it was 382 million people in 2013; and it is estimated that it will be doubled by 2030. [2][3][4][5] As it is mentioned, in DM type 2, in which body cells cannot use the produced insulin, although the blood glucose level is high but cells cannot use it as energy source; instead they use lipids to produce energy resulting in dyslipidemia in DM type 2 patients. In these patients high blood glucose level is define as high fasting blood sugar and high HbA1c and dyslipidemia is defined as high total cholesterol (T-Chol), Triglyceride (Tg), low density lipoprotein (LDL) and low high density lipoprotein (HDL) of blood.…”

Section: Introductionmentioning

confidence: 99%